News
Why 2017 Was a Year to Forget for Pfizer Inc.
The S&P 500 index soared 19% in 2017 (so far). The healthcare sector performed even better, with year-to-date gains of close to 21%. Several major drugmakers completed significant....
AbbVie Makes Progress on Quest to Diversify
AbbVie's (NYSE: ABBV) Humira will face-off against cheaper biosimilars in the coming years, and that's bad news because Humira generates about two-thirds of AbbVie's companywide....
This Is Why Global Blood Therapeutics Inc. Is Sinking Today
In response to the company announcing data from a case study at the American Society of Hematology meeting in Atlanta, shares of Global Blood Therapeutics (NASDAQ: GBT), a clinical-stage biotech....
3 Reasons Spark Therapeutics Is a Buy After Its Crash
After Spark Therapeutics and competitor BioMarin Therapeutic (NASDAQ: BMRN) updated investors on the progress that they're making developing competing gene therapies for hemophilia, investors....
Here's Why Inovio Pharmaceuticals Inc. Fell 21.3% in November
Shares of Inovio Pharmaceuticals Inc. (NASDAQ: INO), a biopharmaceutical company developing vaccines, fell 21.3% in November according to data from S&P Global Market Intelligence. Despite....
Here's Why GlycoMimetics Is Soaring 24.3% Higher Today
After unveiling updated results from a trial evaluating GMI-1271 in relapsed or refractory acute myeloid leukemia (AML), GlycoMimetics (NASDAQ: GLYC) shares are surging 24.3% as of noon EST....
BASTIDE : ACQUISITION OF UK-BASED BAYWATER HEALTHCARE
Bastide Group has announced that it has signed an agreement for the acquisition of the entire share capital of Baywater Healthcare, previously owned by European investment fund Duke....
BASTIDE : ACQUISITION DE LA SOCIETE ANGLAISE BAYWATER HEALTHCARE
Le Groupe Bastide annonce avoir conclu un protocole d'accord portant sur l'acquisition de 100% du capital de la société Baywater Healthcare, détenue auparavant par le fonds d'investissement....
Here's Why Omeros Corporation Is Gaining More Ground Today
Shares of Omeros Corporation (NASDAQ: OMER) rose as high as 10.8% this morning after the biotech announced a U.S. Food and Drug Administration approval that expands its commercial-stage drug to....
3 Top Healthcare Stocks to Buy in December
If you're looking to put some healthcare stocks in your portfolio this holiday season, then it could be a very good time to consider Welltower Inc (NYSE: HCN), Geron Corporation (NASDAQ: GERN),....
3 Dividend Stocks to Buy on Sale
Stocks that pay out the highest dividend yields aren't always the best ones to buy. Sometimes, the yields are artificially high in advance of a big dividend cut. And sometimes the dividend is....
These 3 Stocks Just Raised Their Dividends
We're getting down to the wire now, with only a few short weeks until the close of 2017. It was a year nearly full to the brim with dividend raises, so income investors will be sorry to see it....
3 Dividend Stocks to Buy on Sale
Stocks that pay out the highest dividend yields aren't always the best ones to buy. Sometimes, the yields are artificially high in advance of a big dividend cut. And sometimes the dividend is....
ASH 2017: CAR-T Wallops Blood Cancer
The American Society of Hematology (ASH) annual meeting this past weekend was chock-full of excitement, including an unexpected snowstorm in Atlanta and a slew of game-changing non-Hodgkin....
What Happened in the Stock Market Today
Stocks moved higher on Monday, with the Dow Jones Industrial Average (DJINDICES: ^DJI) and the S&P 500 (SNPINDEX: ^GSPC) closing at record highs.Data source: Yahoo! Finance.Telecom and tech....
3 Stocks to Hold for the Next 20 Years
As Warren Buffett has said, "It's far better to buy a wonderful company at a fair price than a fair company at a wonderful price." For long-term investors, this rings especially true, as a great....
Here's Why Syros Pharmaceuticals Got Crushed Today
Shares of Syros Pharmaceuticals (NASDAQ: SYRS) dropped by as much as 49.1% Monday after the company provided a clinical update on its lead drug candidate. Investors probably couldn't tell by the....
Why Seattle Genetics, Inc. Fell Today
Seattle Genetics (NASDAQ: SGEN) is down 5.9% as of this writing, having been down as much as 10.5% Friday following a weekend of presentations at the American Society of Hematology (ASH)....
Why Seattle Genetics, Inc. Fell Today
Seattle Genetics (NASDAQ: SGEN) is down 5.9% as of this writing, having been down as much as 10.5% Friday following a weekend of presentations at the American Society of Hematology (ASH)....
Here's Why Spark Therapeutics, Inc. Is Getting Hammered Today
Shares of Spark Therapeutics, Inc. (NASDAQ: ONCE), a biotech developing gene therapies, fell hard this morning after the company reported hemophilia trial data that bodes well for rival BioMarin....
BOIRON : Formulaire de déclaration mensuelle des droits de vote au 30 novembre 2017
Le 11 décembre 2017
Publication
du nombre d'actions composant le capital et du nombre total de droits de vote
(articles L. 233-8 II du code de commerce et 223-16 du règlement général de....
Better Buy: Illumina, Inc. vs. Pacific Biosciences
Rapid advances in the ability to quickly and cheaply sequence DNA and RNA are fueling research in cancer, immunology, complex diseases, forensics, agriculture, and many other areas, while clinical....
Better Buy: Illumina, Inc. vs. Pacific Biosciences
Rapid advances in the ability to quickly and cheaply sequence DNA and RNA are fueling research in cancer, immunology, complex diseases, forensics, agriculture, and many other areas, while clinical....
Better Buy: Illumina, Inc. vs. Pacific Biosciences
Rapid advances in the ability to quickly and cheaply sequence DNA and RNA are fueling research in cancer, immunology, complex diseases, forensics, agriculture, and many other areas, while clinical....
Here's What Pushed Arena Pharmaceuticals, Inc. Up 10.6% in November
Shares of Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), a biotech rising like a phoenix from the ashes of Belviq's commercial flop, rose 10.6% in November, according to data from S&P Global....